The 2024 edition of the Transcatheter Cardiovascular Therapeutics (TCT) conference once again highlighted significant innovations in cardiovascular care. This year’s event in Washington, D.C., featured company updates on all types of technologies, including heart valves, access and closure devices, drug-eluting implants, intravascular lithotripsy (IVL), renal denervation (RDN) and more. Some of the biggest names in […]
MitrAssist Medical
Early-stage MitrAssist touts $1M funding for valve-in-valve device
Early-stage MitrAssist whizzed by it’s hoped-for raise of $600,000, landing $1 million from angel and private investors in support of the company’s mitral valve implant.
